about
Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signalingMolecular biology of lung cancer: clinical implicationsEffect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeRas regulates kinesin 13 family members to control cell migration pathways in transformed human bronchial epithelial cells.MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.Genes and gene ontologies common to airflow obstruction and emphysema in the lungs of patients with COPDArray-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma.SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent mannerASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy.Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5.Targeted therapies for lung cancer: clinical experience and novel agentsEpithelial-mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib.Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker.Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM.Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations.Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC reviewSystematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancerGenomic medicine in non-small cell lung cancer: paving the path to personalized care.ADAM28: a potential oncogene involved in asbestos-related lung adenocarcinomas.Nuclear Receptor Expression and Function in Human Lung Cancer Pathogenesis.Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy.Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer.Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism.CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.Abstract 1855: SCT methylation is a potential cancer biomarker for lung cancerExpression profiling defines a recurrence signature in lung squamous cell carcinomaGene expression of lung squamous cell carcinoma reflects mode of lymph node involvementGene Expression Signature Predicts Recurrence in Lung Adenocarcinoma
P50
Q24597245-C718F5C5-A985-4820-AEFC-F01C1F7FF727Q24610335-23223D22-08EF-4D2C-8685-4D2D18D6D290Q27851703-E0CBDE47-547B-417D-92AA-1ECCE838C4A2Q33631023-B2770679-F466-42B3-B2DD-CF428BF23924Q33691330-0A22C280-5FC5-4D23-82E5-D5050FCA59B1Q33851317-0DE46782-4364-4B79-82B2-E4CB781C33C9Q34169994-EE5F655A-1C5A-4C00-BC45-A549706F1514Q34229779-7314BA15-DA7B-4560-956A-81E3CA12605FQ34383742-44011081-6D36-4863-B7A5-F7ED67F8FB31Q34701196-5CD0890F-4124-4936-B3E2-F19C4AE2CEFFQ35434177-4BF774E5-2BA5-46D5-869C-9DB37F862977Q36054970-65EC8314-99D2-4940-A77A-B9FD0CFDC091Q36446988-069E4488-9096-4443-A4C0-A8675918E00DQ36639108-5E377C7A-778E-4664-8F80-80EC7FB8F8CDQ36733222-6F411BD7-338D-4BEB-9E3A-70103F511110Q36782058-D2B08C7F-2683-4F9B-B3B7-7BF712CE7AC9Q36941497-CA6120D0-3D01-4D55-B108-3EF2BD74684DQ37306050-33752454-8BA3-48A6-9A3A-76B10970CB34Q37331472-FCA63A72-B302-47DC-B434-82DE7FDCDAFEQ37806311-5FB55273-F16F-42F4-8924-BB93B7C9AF19Q38506086-CA13E224-9D0F-4D01-97E2-71D88D5F409DQ38846195-0CD60ED6-25A2-4575-B7D8-5E35BD005D3DQ38986353-B8026CFD-DB88-4BD7-9AAC-294FFC743FD6Q45927548-1DD9CAEE-7F86-41D9-B52E-42C065888C2DQ46573353-6A84102F-7565-424B-906A-BBE4D76728BFQ46728745-88F0939A-27D7-4191-AB8A-F0411BE7B51BQ60185082-9B55E74E-4DBA-4592-AD26-0452319E5E5DQ60185098-932A6030-A5D3-40E1-B6E0-DC73DDDA4404Q60185099-AC85626A-388D-4823-95B0-FCA86353D0BCQ60185101-B680B346-417F-4CA2-A5AA-14460534C520
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jill Everland Larsen
@ast
Jill Everland Larsen
@en
Jill Everland Larsen
@es
Jill Everland Larsen
@nl
Jill Everland Larsen
@sl
type
label
Jill Everland Larsen
@ast
Jill Everland Larsen
@en
Jill Everland Larsen
@es
Jill Everland Larsen
@nl
Jill Everland Larsen
@sl
prefLabel
Jill Everland Larsen
@ast
Jill Everland Larsen
@en
Jill Everland Larsen
@es
Jill Everland Larsen
@nl
Jill Everland Larsen
@sl
P1053
G-3787-2010
P106
P21
P31
P3829
P496
0000-0001-7806-3931